Fazleen Haslinda Mohd Hatta

Systematic Pharmacogenomics Analysis of a Malay Whole Genome: Proof of Concept for Personalized Medicine

Mohd Zaki Salleh, Lay Kek Teh, Lian Shien Lee et al. · PLoS ONE · 2013 · 30 citations · Full text

Differences in <i>CYP2C9</i> Genotype and Enzyme Activity Between Swedes and Koreans of Relevance for Personalized Medicine: Role of Ethnicity, Genotype, Smoking, Age, and Sex

Fazleen Haslinda Mohd Hatta, Mia Lundblad, Margareta Ramsjö et al. · OMICS A Journal of Integrative Biology · 2015 · 23 citations

Lower CYP2C9 activity in Turkish patients with Behçet’s disease compared to healthy subjects: a down-regulation due to inflammation?

Mustafa Tuğrul Göktaş, Fazleen Haslinda Mohd Hatta, Özgür Karaca et al. · European Journal of Clinical Pharmacology · 2015 · 16 citations

Inflammation, Turkish Patients, Allergy +11

Search for the molecular basis of ultra-rapid CYP2C9-catalysed metabolism: relationship between SNP IVS8-109A&gt;T and the losartan metabolism phenotype in Swedes

Fazleen Haslinda Mohd Hatta, Lay Kek Teh, Anders Helldén et al. · European Journal of Clinical Pharmacology · 2012 · 15 citations

Snp Ivs8-109a, Biochemistry, Natural Sciences +8